Safety and Efficacy of Intravenous Alteplase before Endovascular Thrombectomy: A Pooled Analysis with Focus on the Elderly.
acute ischemic stroke
elderly
endovascular thrombectomy
intravenous alteplase
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
26 Jun 2022
26 Jun 2022
Historique:
received:
17
05
2022
revised:
17
06
2022
accepted:
23
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
10
7
2022
Statut:
epublish
Résumé
Current guidelines advocate intravenous thrombolysis (IVT) prior to endovascular thrombectomy (EVT) for all patients with acute ischemic stroke (AIS) due to large vessel occlusion (LVO). We evaluated outcomes with and without IVT pretreatment. Our institutional protocols allow AIS patients presenting early (<4 h from onset or last seen normal) who have an Alberta Stroke Program Early CT Score (ASPECTS) ≥6 to undergo EVT without IVT pretreatment if the endovascular team is in the hospital (direct EVT). Rates of recanalization and hemorrhagic transformation (HT) and neurological outcomes were retrospectively compared in consecutive patients undergoing IVT+EVT vs. direct EVT with subanalyses in those ≥80 years and ≥85 years. In the overall cohort (IVT+EVT = 147, direct EVT = 162), and in subsets of patients ≥80 years (IVT+EVT = 51, direct EVT = 50) and ≥85 years (IVT+EVT = 19, direct EVT = 32), the IVT+EVT cohort and the direct EVT group had similar baseline characteristics, underwent EVT after a comparable interval from symptom onset, and reached similar rates of target vessel recanalization. No differences were observed in the HT frequency, or in disability at discharge or after 90 days. Patients receiving direct EVT underwent more stenting of the carotid artery due to stenosis during the EVT procedure (22% vs. 6%, p = 0.001). Direct EVT and IVT+EVT had comparable neurological outcomes in the overall cohort and in the subgroups of patients ≥80 and ≥85 years, suggesting that direct EVT should be considered in patients with an elevated risk for HT.
Identifiants
pubmed: 35806966
pii: jcm11133681
doi: 10.3390/jcm11133681
pmc: PMC9267603
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
JAMA. 1995 Oct 4;274(13):1017-25
pubmed: 7563451
Stroke. 2022 May;53(5):1674-1681
pubmed: 34872341
Scott Med J. 1957 May;2(5):200-15
pubmed: 13432835
Stroke. 2014 Feb;45(2):444-9
pubmed: 24335227
N Engl J Med. 2020 May 21;382(21):1981-1993
pubmed: 32374959
J Clin Med. 2022 Feb 22;11(5):
pubmed: 35268253
Stroke. 2021 Mar;52(3):1098-1104
pubmed: 33504188
Front Neurol. 2021 Jun 10;12:649108
pubmed: 34177759
Circulation. 2011 Sep 6;124(10):1132-7
pubmed: 21875913
Stroke. 1989 Jul;20(7):864-70
pubmed: 2749846
Neurology. 2015 Sep 15;85(11):927-4
pubmed: 26296519
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Lancet. 1998 Oct 17;352(9136):1245-51
pubmed: 9788453
Stroke. 2019 Dec;50(12):e344-e418
pubmed: 31662037
AJNR Am J Neuroradiol. 2015 Oct;36(10):1953-8
pubmed: 26272977
Radiology. 2015 May;275(2):510-20
pubmed: 25633505
JAMA. 2021 Jan 19;325(3):234-243
pubmed: 33464335
Stroke. 2003 Aug;34(8):e109-37
pubmed: 12869717
N Engl J Med. 2021 Nov 11;385(20):1833-1844
pubmed: 34758251
Stroke. 2017 Sep;48(9):2450-2456
pubmed: 28747462
JAMA. 2021 Jan 19;325(3):244-253
pubmed: 33464334
Cardiovasc Intervent Radiol. 2022 Jun;45(6):826-833
pubmed: 35296934
J Am Heart Assoc. 2019 Jun 4;8(11):e011592
pubmed: 31140355
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
Stroke. 2022 Jan;53(1):17-19
pubmed: 34915740
N Engl J Med. 2008 Sep 25;359(13):1317-29
pubmed: 18815396